Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on PCRX
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
PACIRA (NQ:PCRX)
Delayed:
29.44
+0.27 (0.93%)
Trade Now!
Previous Close
$29.17
52 Week High
$30.94
Open
$29.33
52 Week Low
$9.81
Day High
$29.69
P/E
N/A
Day Low
$29.26
EPS
$-1.98
Volume
1,390,122
Friends, Peers and Foes
(?)
:
NDAQ
,
WCRX
,
MRX
,
FRX
AMRN
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 17, 2013 06:02 PM
Form 4 Pacira Pharmaceuticals, For: May 15 Filed by: HASTINGS PAUL J
May 8, 2013 12:56 PM
Form 4 Pacira Pharmaceuticals, For: Apr 12 Filed by: EVNIN LUKE
May 8, 2013 12:04 PM
Form 10-Q Pacira Pharmaceuticals, For: Mar 31
May 8, 2013 08:03 AM
Form 8-K Pacira Pharmaceuticals, For: May 08
May 8, 2013 06:40 AM
Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 8, 2013 06:30 AM
Pacira Pharmaceuticals, Inc. Reports $10.4 Million in First Quarter EXPAREL Revenue and Full First Quarter 2013 Financial Results
May 6, 2013 04:00 PM
Two New Studies Support Use of EXPAREL via Infiltration Into the Transversus Abdominis Plane for Postsurgical Pain Control
May 1, 2013 06:30 AM
Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
Apr 29, 2013 04:51 PM
Form 4 Pacira Pharmaceuticals, For: Apr 23 Filed by: EVNIN LUKE
Apr 25, 2013 07:52 PM
Form 4 Pacira Pharmaceuticals, For: Apr 23 Filed by: Wicki Andreas
View All Articles
Mar 7, 2013 06:34 AM
Pacira Pharmaceuticals (PCRX) Posts Q4 Loss of 50c/Share
Nov 1, 2012 06:43 AM
Pacira Pharmaceuticals (PCRX) Posts Q3 Loss of 49c/Share
Aug 9, 2012 06:36 AM
Pacira Pharmaceuticals (PCRX) Posts Q2 Loss of 27c/Share
Mar 27, 2012 06:31 AM
Pacira Pharmaceuticals (PCRX) Posts Q4 Loss of 72c/Share
Oct 31, 2011 06:34 AM
Pacira Pharmaceuticals (PCRX) Posts Narrower than Expected Q3 Loss; Guides FY11 Revs
Aug 11, 2011 06:36 AM
Pacira Pharmaceuticals Inc. (PCRX) Tops Q2 EPS by 7c; Reaffirms Outlook
Mar 13, 2013 09:48 AM
Pacira Pharmaceuticals (PCRX) May Need to Come Back Down to Earth - Blog
Mar 7, 2013 06:34 AM
Pacira Pharmaceuticals (PCRX) Posts Q4 Loss of 50c/Share
Jan 18, 2013 01:39 PM
Pacira (PCRX) Financing Deal Removes Overhang
Jan 17, 2013 08:08 AM
Pacira Pharma (PCRX) Prices $110M Convertible Notes Offering
Jan 16, 2013 09:32 AM
StreetInsider.com Pre-Open Movers 01/16: (GNW) (CBK) (VRA) Higher; (CMG) (BA) (GM) Lower (more...)
Jan 15, 2013 05:41 PM
Streetinsider.com After-Hours Movers 1/15: (CBK) (VRA) Higher; (PLUG) (CIE) (STAG) Lower (more...)
Jan 15, 2013 04:27 PM
Pacira Pharma (PCRX) Prelim. Q4, FY12 Revs Come in Ahead of Views
Dec 12, 2012 07:41 AM
Pacira Pharma (PCRX) CEO Stack Joins Amarin's (AMRN) Board
Dec 6, 2012 06:31 AM
Pacira Pharma (PCRX), Aratana Enter Bupivacaine Liposome Licensing Agreement
Nov 16, 2012 01:44 PM
Pacira Pharma's (PCRX) Exparel Could Be $1 Billion Product
View All Reports
May 8, 2013 06:40 AM
Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 8, 2013 06:30 AM
Pacira Pharmaceuticals, Inc. Reports $10.4 Million in First Quarter EXPAREL Revenue and Full First Quarter 2013 Financial Results
May 6, 2013 04:00 PM
Two New Studies Support Use of EXPAREL via Infiltration Into the Transversus Abdominis Plane for Postsurgical Pain Control
May 1, 2013 06:30 AM
Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
Apr 25, 2013 06:30 AM
New Published Analysis Finds Opioid-Related Adverse Events Increase Hospital Stays, Costs of Care and Risks of Readmission and Mortality
Apr 12, 2013 06:30 AM
New Data Support the Benefits of EXPAREL for Postsurgical Analgesia Following Aesthetic Plastic Surgery Procedures
Apr 5, 2013 10:00 AM
Pacira Pharmaceuticals, Inc. [PCRX] to Ring The NASDAQ Stock Market Closing Bell
Apr 5, 2013 06:30 AM
Pacira Pharmaceuticals, Inc. to Close The NASDAQ Stock Market on April 8, 2013
Mar 27, 2013 06:30 AM
Analysis of Postsurgical Pain Management Finds Opioid-Related Adverse Events Drive Longer Hospital Stays, Greater Cost and Higher Likelihood of Readmission
View All Press Releases
May 17, 2013 06:02 PM
Form 4 Pacira Pharmaceuticals, For: May 15 Filed by: HASTINGS PAUL J
May 8, 2013 12:56 PM
Form 4 Pacira Pharmaceuticals, For: Apr 12 Filed by: EVNIN LUKE
May 8, 2013 12:04 PM
Form 10-Q Pacira Pharmaceuticals, For: Mar 31
May 8, 2013 08:03 AM
Form 8-K Pacira Pharmaceuticals, For: May 08
Apr 29, 2013 04:51 PM
Form 4 Pacira Pharmaceuticals, For: Apr 23 Filed by: EVNIN LUKE
Apr 25, 2013 07:52 PM
Form 4 Pacira Pharmaceuticals, For: Apr 23 Filed by: Wicki Andreas
Apr 18, 2013 05:12 PM
Form 4 Pacira Pharmaceuticals, For: Apr 12 Filed by: EVNIN LUKE
Apr 17, 2013 06:30 PM
Form 4 Pacira Pharmaceuticals, For: Apr 15 Filed by: Wicki Andreas
Apr 16, 2013 02:50 PM
Form 4 Pacira Pharmaceuticals, For: Apr 12 Filed by: PATOU GARY
Apr 15, 2013 08:12 PM
Form 4 Pacira Pharmaceuticals, For: Mar 25 Filed by: MIDDLETON FRED A
View All Filings
Entities mentioned with
PCRX
Earnings
|
View Related Stories »
Brean Murray Carret & Co.
|
View Related Stories »
Barclays
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
Dollar Thrifty Takeover
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
JPMorgan
|
View Related Stories »
13D
|
View Related Stories »
Morning Movers
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Bank of America
|
View Related Stories »
Standard & Poor's
|
View Related Stories »
Deutsche Bank
|
View Related Stories »
Trading Radar
|
View Related Stories »
William Ackman
|
View Related Stories »
Bankruptcy
|
View Related Stories »
After-Hours Movers
|
View Related Stories »
Twitter
|
View Related Stories »
Central Securities Corp.
|
View Related Stories »
Unusual 11 Mid-Day Movers
|
View Related Stories »
Chicago PMI
|
View Related Stories »
S1
|
View Related Stories »
American Technology Research
|
View Related Stories »
Crude Oil
|
View Related Stories »
Consumer Confidence Index
|
View Related Stories »
Show More...
View All Entities